Matri

Roni Mondal and Rohan Roy are Season 3's most personally mission-driven male founders solving a female health crisis. Two school friends from Kolkata who studied engineering together, they recognised during their second year of college that 80% of Indian women experience menstrual pain for 30 to 40 years of their lives, yet India had no effective, accessible, drug-free solution beyond painkillers (with side effects) and hot water bottles (inconvenient and temporary). They incorporated Silifarm Technologies in 2019, began incubation at IIT Patna, and spent years developing and iterating the Matri device using their personal savings. The device underwent extensive field studies, user-experience testing, and prototype iterations before arriving at the final product.

Matri is India's first and slimmest wearable TENS-based period pain relief device, providing drug-free, non-invasive menstrual cramp relief within 10 to 15 minutes through targeted electrical nerve stimulation that blocks pain signals from reaching the brain. The device combines TENS therapy with ComfortWave technology in a dual-mode system (wired and wireless), 30 adjustable intensity levels for personalised pain management, and a smart memory mode that remembers the user's preferred settings. TENS therapy works by sending low-voltage electrical pulses through self-adhesive gel pads placed on the lower abdomen. These pulses stimulate nerve fibres, blocking pain signal transmission and triggering the body's natural endorphin release. The 96% positive feedback rate from 400 plus women tested confirms clinical efficacy that painkillers achieve through chemical intervention and hot water bottles achieve through temporary surface heat.

Amount Asked: ₹60 lakhs Equity Offered: 4% Implied Pre-Money Valuation: ₹15 crore

Roni and Rohan walked into Season 3 Episode 24 with the most universally praised social mission pitch of the entire season. They opened with the statistic that resonated with every woman watching: 80% of women experience menstrual pain, and they endure it for 30 to 40 years of their lives. Then they demonstrated Matri: a simple, portable, wearable device that provides relief in 10 to 15 minutes without drugs. Anupam Mittal's spontaneous "You are Padman 2.0, the modern version of Padman. What mission you have taken on... fantastic!" was Season 3 Episode 24's most powerfully endorsing Shark declaration. Vineeta Singh thanked the founders personally. Every Shark wanted to invest, creating the most positively competitive bidding environment of the episode.

Anupam Mittal called the founders "Padman 2.0" and made the first offer at ₹60 lakhs for 10% equity. Namita Thapar immediately matched Anupam's initial offer and wanted to invest solo. She revised from 10% to 6% to 4% equity through the bidding process, and ultimately joined Aman in the winning coalition. Vineeta Singh offered ₹60 lakhs for 6% equity and personally thanked the founders for solving this problem. Aman Gupta offered ₹60 lakhs for 4% equity, matching the founders' exact ask. Ritesh Agarwal escalated the competition by offering ₹1 crore for 4% equity (₹25 crore valuation), arguing the founders needed more capital.

The most competitive all-Shark bidding war of Season 3 Episode 24 unfolded across multiple rounds. Anupam opened at ₹60L for 10%. Namita matched at 10%. Vineeta offered at 6%. Anupam revised to 4%. Namita revised to 6%, then 4%. Aman offered at 4% (matching the ask). Ritesh escalated to ₹1 crore for 4%. Anupam exited at ₹25 crore valuation. The founders asked Namita to combine with Aman, which she accepted. Final deal: ₹60 lakhs for 4% equity from Aman and Namita at ₹15 crore valuation.

Roni Mondal and Rohan Roy accepted Aman Gupta and Namita Thapar's combined offer of ₹60 lakhs for 4% equity at ₹15 crore valuation. The founders chose this combination over Ritesh's higher ₹1 crore offer because Aman's wearable electronics manufacturing expertise (boAt) and Namita's pharmaceutical healthcare distribution network (Emcure) were the most strategically complementary capabilities for scaling a medical-grade wearable device: Aman for product manufacturing, supply chain, and D2C distribution; Namita for clinical credibility, hospital and pharmacy distribution, and women's healthcare positioning.

Matri has launched Matri Pro, India's slimmest dual-mode period pain relief device, now available exclusively on mymatri.com. The device is a CDSCO Certified Class B Medical Device with dual-mode TENS and ComfortWave technology, 30 adjustable intensity levels, USB recharging, and reusable gel pads lasting up to 30 uses. Since its debut on Shark Tank India Season 3, Matri has been on a mission to reshape the conversation around menstruation and bring real change to the lives of Indian women. The company has expanded beyond the device into menstrual health education, partnering with schools for workshops teaching girls about menstrual health and hygiene, and involving boys in the conversation to create informed future generations. NGO partnerships extend this impact to underprivileged communities where access to menstrual education and products is limited. The founders' vision extends beyond period pain to labor pain relief (using TENS therapy) and Matri 2.0 (next-generation device with enhanced features), creating a comprehensive women's pain management product pipeline from a single core TENS technology platform.